IDiyas

For the Inventor, By the Inventor

Osaka, Japan

Kenji Okonogi

USPTO Granted Patents = 16

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 85(Granted Patents)


Location History:

  • Mishima, JP (1988 - 1995)
  • Shimamoto, JP (1994 - 1995)
  • Shimamoto-cho, JP (1996)
  • Mishima-gun, JP (1996 - 1998)
  • Osaka, JP (1995 - 2002)

Company Filing History:

goldMedal15 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents
silverMedal1 out of 1 
 
Takeda Chemical Industries, Co., Ltd.
 patent

Years Active: 1988-2002

Loading Chart...
16 patents (USPTO):Explore Patents
1. 6407129 - Azole compounds, their production and their use (2002-06-18),
2. 6362206 - Azole compounds, their production and use (2002-03-26),
3. 6034248 - Azole compounds, their production and use (2000-03-07),
4. 5948774 - Cephem compounds, their production and use (1999-09-07),
5. 5792780 - Azole compounds, their production and use (1998-08-11),
6. 5545652 - Triazole and imidazole compounds and their use as antifungal therapeutic (1996-08-13),
7. 5495024 - Optically active azole compounds and their production (1996-02-27),
8. 5466820 - Production of Di or tri-azolyl substituted 5-keto azole compounds (1995-11-14),
9. 5438053 - Cephem compounds compositions and method (1995-08-01),
10. 5405861 - Triazole compounds and antifungal compositions thereof (1995-04-11),
11. 5389663 - 1-(1h-1,2,4-triazole-yl)-2-propanol compounds (1995-02-14),
12. 5387599 - Triazoles, their production and use (1995-02-07),
13. 5371101 - Azole compounds, their production and use (1994-12-06),
14. 5371100 - Optically active tetrazole compounds, and fungicidal compositions thereof (1994-12-06),
15. 5177094 - Triazole compounds having antifungal properties (1993-01-05),

Title: Kenji Okonogi: Innovator in Azole Compounds

Introduction

Kenji Okonogi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of chemistry, particularly in the development of azole compounds. With a total of 16 patents to his name, Okonogi's work has had a substantial impact on antifungal treatments.

Latest Patents

One of Okonogi's latest patents focuses on azole compounds, their production, and their use. This patent describes a quaternized nitrogen-containing imidazol-1-yl or 1,2,4-triazol-1-yl compound. The innovation involves a substituent that can be eliminated in vivo, converting it into an antifungal azole compound. This compound boasts improved solubility in water, making it suitable for injection. Additionally, it has enhanced internal absorption and is expected to be effective in treating or preventing diseases.

Career Highlights

Throughout his career, Kenji Okonogi has worked with notable companies, including Takeda Chemical Industries, Inc. and Takeda Chemical Industries, Co., Ltd. His expertise in the field has led to numerous advancements in pharmaceutical chemistry.

Collaborations

Okonogi has collaborated with esteemed colleagues such as Katsumi Itoh and Akihiro Tasaka. These partnerships have fostered innovation and contributed to the success of his research endeavors.

Conclusion

Kenji Okonogi's work in azole compounds exemplifies the importance of innovation in the pharmaceutical industry. His contributions continue to influence the development of effective treatments for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…